Ledwoch, Jakob
Staubach, Stephan
Akin, Ibrahim
Ince, Hüseyin
Zeymer, Uwe
Pleger, Sven
Sievert, Horst
Hochadel, Matthias
Senges, Jochen
Lewalter, Thorsten
Brachmann, Johannes
Mudra, Harald
Funding for this research was provided by:
Boston Scientific Corporation
Stiftung Institut für Herzinfarktforschung
Article History
Received: 4 June 2021
Accepted: 11 October 2021
First Online: 23 October 2021
Declarations
:
: Jakob Ledwoch: none.Stephan Staubach: none.Ibrahim Akin: none.Hüseyin Ince: none.Uwe Zeymer: none.Sven Pleger: none.Horst Sievert: Study honorary, travel expenses, consulting fees from Access Closure, AGA, Angiomed, Ardian, Arstasis, Atritech, Atrium, Avinger, Bard, Boston Scientific, Bridgepoint, CardioKinetix, CardioMEMS, Coherex, Contego, CSI, EndoCross, EndoTex, Epitek, Evalve, ev3, FlowCardia, Gore, Guidant, Lumen Biomedical, HLT, Kensey Nash, Kyoto Medical, Lifetech, Lutonix, Medinol, Medtronic, NDC, NMT, OAS, Occlutech, Osprey, Ovalis, Pathway, PendraCare, Percardia, pfm Medical, Recor, Rox Medical, Sadra, Sorin, Spectranetics, SquareOne, Trireme, Trivascular, Viacor, Velocimed, Veryan.Stock options from Cardiokinetix, Access Closure, Velocimed, CoAptus, Lumen Biomedical, Coherex.Jochen Senges, Matthias Hochadel: Stiftung IHF received an unrestricted grant from Boston Scientific (Marlborough,MA, USA) for performing statistical analyses.Thorsten Lewalter: Speaker honorary from St. Jude Medical/Abbott Vascular and Boston Scientific.Johannes Brachmann: none.Harald Mudra: none.